Genmab — November 2018
-
Amgen fik Kyprolis godkendt 4 mdr efter data release på ny dosering weekly i stedet for to https://www.amgen.com/media/news-releases/2018/10/fda-approves-kyprolis-carfilzomib-onceweekly-70-mgm2-in-combination-with-dexamethasone-kd70-for-patients-with-relapsed-or-refractory-multiple-myeloma/
-
Men der var jo ikke tale om en ny opskrift. Det er der med dara sc + rhuph20. Supplements with CMC formulation changes and supplements with pharmacology/toxicology data will be excluded. https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OCE/ucm612927.htm
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind